DK582588A - Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse - Google Patents

Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse

Info

Publication number
DK582588A
DK582588A DK582588A DK582588A DK582588A DK 582588 A DK582588 A DK 582588A DK 582588 A DK582588 A DK 582588A DK 582588 A DK582588 A DK 582588A DK 582588 A DK582588 A DK 582588A
Authority
DK
Denmark
Prior art keywords
c2h4o
compound
present
treating
hltv
Prior art date
Application number
DK582588A
Other languages
English (en)
Other versions
DK582588D0 (da
Inventor
Robert L Hunter
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of DK582588D0 publication Critical patent/DK582588D0/da
Publication of DK582588A publication Critical patent/DK582588A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK582588A 1987-02-20 1988-10-19 Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse DK582588A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1733087A 1987-02-20 1987-02-20
US15073188A 1988-02-16 1988-02-16
PCT/US1988/000510 WO1988006038A1 (en) 1987-02-20 1988-02-19 Antiinfective compounds and method of use

Publications (2)

Publication Number Publication Date
DK582588D0 DK582588D0 (da) 1988-10-19
DK582588A true DK582588A (da) 1988-12-12

Family

ID=26689732

Family Applications (1)

Application Number Title Priority Date Filing Date
DK582588A DK582588A (da) 1987-02-20 1988-10-19 Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse

Country Status (9)

Country Link
EP (1) EP0305470B1 (da)
JP (1) JPH01503458A (da)
AT (1) ATE82129T1 (da)
AU (1) AU1396588A (da)
CA (1) CA1314221C (da)
DE (1) DE3875871T2 (da)
DK (1) DK582588A (da)
FI (1) FI884850A0 (da)
WO (1) WO1988006038A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
JP2647556B2 (ja) 1991-03-19 1997-08-27 サイトアーレクス・コーポレーシヨン 改良された生物学的活性を有するポリオキシプロピレン／ポリオキシエチレン共重合体類
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
EP0682524B1 (en) * 1993-02-02 2001-10-04 XOMA Technology Ltd. Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
US6214789B1 (en) 1993-03-12 2001-04-10 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5932544A (en) 1994-05-31 1999-08-03 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
DE10358534A1 (de) 2003-12-13 2005-07-14 Henkel Kgaa Adhäsionshemmung von Mikroorganismen durch nichtionische Tenside
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US3140232A (en) * 1962-12-19 1964-07-07 Pfizer & Co C Color stabilization of tetracycline compositions with polypropylene glycols
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
JPS5283936A (en) * 1976-01-01 1977-07-13 Ortho Pharma Corp Single herpes virus inactivating acent
DE2732929A1 (de) * 1977-07-21 1979-02-01 Bayer Ag Polyaether, verfahren zu ihrer herstellung sowie ihre verwendung als lipidabsorptionshemmer
JPS5449322A (en) * 1977-09-26 1979-04-18 Daicel Chem Ind Ltd Non-medical anti-bacterial and anti-mold agent
JPS5668616A (en) * 1979-11-08 1981-06-09 Yukio Kimura Preparation of antibiotic composition
JPS579717A (en) * 1980-06-20 1982-01-19 Nippon Shinyaku Co Ltd Germicidal composition
US4376118A (en) * 1980-10-06 1983-03-08 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung

Also Published As

Publication number Publication date
CA1314221C (en) 1993-03-09
JPH01503458A (ja) 1989-11-22
ATE82129T1 (de) 1992-11-15
DK582588D0 (da) 1988-10-19
DE3875871T2 (de) 1993-04-01
DE3875871D1 (de) 1992-12-17
AU1396588A (en) 1988-09-14
WO1988006038A1 (en) 1988-08-25
FI884850A (fi) 1988-10-20
EP0305470A1 (en) 1989-03-08
FI884850A0 (fi) 1988-10-20
EP0305470B1 (en) 1992-11-11

Similar Documents

Publication Publication Date Title
DK582588A (da) Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse
Giamarellou et al. In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa
CA2006953A1 (en) Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
YU53093A (sh) Benzoksazinoni kao inhibitori hiv reverzne transkriptaze
FI962488A0 (fi) HIV:n proteaasin inhibiittoreita
Steele Recurrent staphylococcal infection in families
Lawrence et al. Quantitative microbiology of traumatic orthopedic wounds
Brogden et al. Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific
Chirino-Trejo et al. Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer (Odocoileus virginianus) with necrobacillosis
US3792161A (en) Burn ointment comprising silver sulfadiazine and collagenase
Holton et al. Mycobacterium haemophilum infection in a patient with AIDS
Vanhoof et al. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms
Berger et al. Penetration of clindamycin into decubitus ulcers
Mallory et al. Local immunization of rabbits to cutaneous infection with Staphylococcus aureus
Swerczek Inhibition of the CEM organism by the normal flora of the reproductive tract
ES442505A1 (es) Procedimiento de preparacion de la 4-0-n2',6'-diamino-2',3',6' - tridesoxi-alfa, d-ribohexopiranosiln6-0 - n3" - metila-mino-3",4",6"tridesoxi alfa,d-xilohexopiranosiln2-desoxies- treptamina.
Bisgaard et al. Isolation of Pasteurella caballi from an infected wound on a veterinary surgeon
US4096245A (en) Prophylactic preparation for treating mink infection caused by Pseudomonas aeruginosa
Dyas et al. Sources of staphylococcal wound sepsis in surgical patients
Wilmot et al. Aureomycin in amebic liver abscess
Soliman et al. STUDIES ON HISTOPLASMOSIS FARCIMINOSSII (EPIZOOTIC LYMPHANGITIS) IN EGYPT IV-The biochemical characters of local isolates of Histoplasma Farcimonosum and their sensitiity to antimycotic and disinfectants in vitro
Hüffler In-vitro sensitivity of Bacteroidaceae, clostridia and propionibacteria to newer antimicrobial agents
Hewitt Effect of chemotherapeutic agents on C. diphtheriae, with special reference to the diamidines
Scott The bacterial flora of the gastric stump
Thörne et al. Treatment of bovine staphylococcal mastitis with staphylococcal toxoid

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment